Dynamic Dashboard

The Global AMR R&D Hub’s Dynamic Dashboard continuously collects and presents information on more than 8 bn USD AMR R&D investments from across the One Health continuum – human, animal, plant and environment. It also presents information on antibacterial products in the clinical development pipeline and incentives for antibiotic R&D.

Cloud-based visualization of data serves science in the global fight against resistant pathogens

08.10.2021: Where science meets digitalization: the Global Antimicrobial Resistance Research and Development Hub, or Global AMR R&D Hub, works with huge amounts of research data from all around the world. In its mission to combat resistance to antimicrobial medication, the Hub needed a ...

Public and philanthropic investments in AMR R&D related to animal health vaccines

30.08.2021: Antimicrobial resistance (AMR) not only poses a global threat to public health but also has severe implications for the health and welfare of animal populations. We are pleased to publish a new report that focuses on the current state of R&D funding for animal health vaccine...

Study Publication: Estimating global market potential for priority health technologies addressing AMR

19.08.2021: One of the challenges inhibiting a more unified and co-ordinated global action in the field of AMR product development incentives is a lack of evidence or data to quantify the need or size of the challenge and therefore the scale of the required intervention. A multidiscipli...

Funded by: